Antiglutamate Anticonvulsants in the Treatment of Alcohol Withdrawal Syndrome

N/ACompletedNCT00241995

St. Petersburg State Pavlov Medical University

Overview

The study is aimed to evaluate the efficacy of antiglutamate anticonvulsants (topiramate, lamotrigine, and memantine) in the treatment of alcohol withdrawal syndrome

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Conditions

Topiramate Lamotrigine Memnatine Diazepam Placebo

Interventions

AnticonvulsantsDRUG

Eligibility

Sex: ALLMin age: 20 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: Alcohol dependence Alcohol withdrawal syndrome Exclusion Criteria: Drug dependence Major psychiatric diagnoses Severe somatic illness

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.